Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis.
复制标题
DOI:
10.1158/0008-5472.can-09-3880
复制
发表时间:
2010-11-15
期刊:
影响因子:
11.2
通讯作者:
Raz A
中科院分区:
文献类型:
--
作者:
Niinaka Y;Harada K;Fujimuro M;Oda M;Haga A;Hosoki M;Uzawa N;Arai N;Yamaguchi S;Yamashiro M;Raz A
Phosphoglucose isomerase (PGI) is a multifunctional enzyme that functions in glucose metabolism as a glycolytic enzyme catalyzing an interconversion between glucose and fructose inside the cell, while, PGI acts as cytokine outside the cell, with properties that include autocrine motility factor (AMF) regulating tumor cell motility. Overexpression of AMF/PGI induces epithelial to mesenchymal transition (EMT) with enhanced malignancy. Recent studies have revealed that silencing of AMF/PGI resulted in mesenchymal to epithelial transition (MET) of human lung fibrosarcoma cells and breast cancer cells with reduced malignancy. Here, we constructed a hammerhead ribozyme specific against GUC triplet at the position G390 in the human, mouse, and rat AMF/PGI mRNA sequence. Mesenchymal human osteosarcoma MG-63, H S-Os-1, and murine LM8 cells were stably transfected with the ribozyme specific for AMF/PGI. The stable transfectant cells showed effective down-regulation of AMF/PGI expression and subsequent abrogation of AMF/PGI secretion, which resulted in morphological change with reduced growth, motility, and invasion. Silencing of AMF/PGI induced MET, in which up-regulation of E-cadherin and cytokeratins as well as down-regulation of vimentin were noted. The MET guided by AMF/PGI gene silencing induced osteosarcoma MG-63 to terminally differentiate into mature osteoblasts. Furthermore, The MET completely suppressed tumor growth and pulmonary metastasis of LM8 cells in nude mice. Thus, acquisition of malignancy might be completed in part by up-regulation of AMF/PGI and waiver of malignancy might be also controlled by down-regulation of AMF/PGI.